Interventional Oncology Devices Market - A Global and Regional Analysis: Focus on Cancer Type, Product Type, End Users, and Country-Wise Analysis - Analysis and Forecast, 2021-2030

Table of Contents

1 Market
1.1 Global Market Outlook
1.1.1 Product Definition
1.1.1.1 Embolization Devices
1.1.1.2 Ablation Devices
1.1.1.3 Supporting Devices
1.1.1.4 Next-Generation Devices
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.1.4 Assumptions and Limitations
1.1.5 Global Market Scenario
1.1.5.1 Realistic Growth Scenario
1.1.5.2 Optimistic Growth Scenario
1.1.5.3 Pessimistic/Conservative Growth Scenario
1.2 Industry Outlook
1.2.1 Key Trends
1.2.1.1 Short-Term Impact
1.2.1.2 Long-Term Impact
1.2.2 Opportunity Assessment
1.2.2.1 Short-Term Potential
1.2.2.2 Long-Term Potential
1.2.3 Patent Analysis
1.2.3.1 Awaited Technological Developments
1.2.3.2 Patent Publication Growth Trend
1.2.3.3 Patent Analysis by Country/Cluster
1.2.4 Product Benchmarking
1.2.5 Ongoing Clinical Trial Studies
1.3 Impact of COVID-19 on the Global Interventional Oncology Devices Market
1.3.1 Impact on Facilities
1.3.2 Impact on Device Adoption
1.3.3 Impact on Market Size
1.3.3.1 Pre-COVID-19 Phase
1.3.3.2 During COVID-19 Phase
1.3.3.3 Post-COVID-19 Phase
1.3.4 Market Entry Barriers and Opportunities
1.4 Business Dynamics
1.4.1 Impact Analysis
1.4.2 Business Drivers
1.4.2.1 High Prevalence and Growing Incidences of Cancer
1.4.2.2 Favorable Reimbursement Scenario for Interventional Oncology Treatment in Developed Economies
1.4.2.3 Expanding Role of Interventional Oncology in the Treatment of Cancer
1.4.2.4 Availability of Private and Government Funding and Grants for Research in the Field of Interventional Oncology
1.4.3 Business Restraints
1.4.3.1 Financial Burden of Product Recalls
1.4.3.2 Lack of Clinical Evidence for Locoregional Treatments
1.4.3.3 Dearth of Trained Interventional Oncologists
1.4.4 Business Opportunities
1.4.4.1 High Growth Opportunity in the Emerging Economies
1.4.4.2 Emergence of Local Companies in Asia-Pacific and the Middle East and Africa

2 Application
2.1 Global Interventional Oncology Devices Market (by Cancer Type)
2.1.1 Opportunity Assessment
2.1.2 Growth Share Matrix
2.1.3 Liver Cancer
2.1.4 Lung Cancer
2.1.5 Kidney Cancer
2.1.6 Prostate Cancer
2.1.7 Other Cancers
2.2 Global Interventional Oncology Devices Market (by End User)
2.2.1 Opportunity Assessment
2.2.2 Growth Share Matrix
2.2.3 Hospitals
2.2.4 Ambulatory Surgical Centers
2.2.5 Others

3 Products
3.1 Global Interventional Oncology Devices Market (by Product Type)
3.1.1 Opportunity Assessment
3.1.2 Growth Share Matrix
3.1.3 Ablation Devices
3.1.3.1 Radiofrequency Ablation
3.1.3.2 Microwave Ablation
3.1.3.3 Cryoablation
3.1.4 Embolization Devices
3.1.4.1 Transcatheter Arterial Chemoembolization (TACE)
3.1.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy
3.1.4.3 Transcatheter Arterial Embolization (TAE)/Bland Embolization
3.1.5 Supporting Devices
3.1.5.1 Catheters
3.1.5.2 Guidewires
3.1.6 Next-Generation Devices
3.1.6.1 Laser Ablation
3.1.6.2 High Intensity Focused Ultrasound (HIFU)
3.1.6.3 Irreversible Electroporation Ablation (IEA)
3.1.6.4 Photothermal Ablation
3.1.6.5 Percutaneous Ethanol Ablation (PEA)
3.1.6.6 Theranostics

4 Region
4.1 North America Interventional Oncology Devices Market
4.1.1 Regulatory Framework
4.1.2 Market
4.1.2.1 Key Findings and Opportunity Assessment
4.1.2.2 Business Drivers
4.1.2.3 Business Restraints
4.1.2.4 Impact Analysis
4.1.2.5 Sizing and Forecast Analysis
4.1.3 Application
4.1.3.1 North America Interventional Oncology Devices Market (by Cancer Type)
4.1.3.2 North America Interventional Oncology Devices Market (by End User)
4.1.4 Product
4.1.4.1 North America Interventional Oncology Devices Market (by Product Type)
4.1.4.1.1 North America Interventional Oncology Devices Market (by Ablation Devices)
4.1.4.1.2 North America Interventional Oncology Devices Market (by Embolization Devices)
4.1.5 North America Interventional Oncology Devices Market (by Country)
4.1.5.1 U.S.
4.1.5.1.1 Market
4.1.5.1.1.1 Business Restraints
4.1.5.1.1.2 Business Drivers
4.1.5.1.1.3 Sizing and Forecast Analysis
4.1.5.1.2 Application
4.1.5.1.2.1 U.S. Interventional Oncology Devices Market (by Cancer Type)
4.1.5.1.2.2 U.S. Interventional Oncology Devices Market (by End User)
4.1.5.1.3 Product
4.1.5.1.3.1 U.S. Interventional Oncology Devices Market (by Product Type)
4.1.5.1.3.1.1 U.S. Interventional Oncology Devices Market (by Ablation Devices)
4.1.5.1.3.1.2 U.S. Interventional Oncology Devices Market (by Embolization Devices)
4.1.5.2 Canada
4.1.5.2.1 Market
4.1.5.2.1.1 Business Restraints
4.1.5.2.1.2 Business Drivers
4.1.5.2.1.3 Sizing and Forecast Analysis
4.1.5.2.2 Application
4.1.5.2.2.1 Canada Interventional Oncology Devices Market (by Cancer Type)
4.1.5.2.2.2 Canada Oncology Devices Market (by End User)
4.1.5.2.3 Product
4.1.5.2.3.1 Canada Interventional Oncology Devices Market (by Product Type)
4.1.5.2.3.1.1 Canada Interventional Oncology Devices Market (by Ablation Devices)
4.1.5.2.3.1.2 Canada Interventional Oncology Devices Market (by Embolization Devices)
4.2 Europe Interventional Oncology Devices Market
4.2.1 Regulatory Framework
4.2.2 Market
4.2.2.1 Key Findings and Opportunity Assessment
4.2.2.2 Business Drivers
4.2.2.3 Business Restraints
4.2.2.4 Impact Analysis
4.2.2.5 Sizing and Forecast Analysis
4.2.3 Application
4.2.3.1 Europe Interventional Oncology Devices Market (by Cancer Type)
4.2.3.2 Europe Interventional Oncology Devices Market (by End User)
4.2.4 Product
4.2.4.1 Europe Interventional Oncology Devices Market (by Product Type)
4.2.4.1.1 Europe Interventional Oncology Devices Market (by Ablation Devices)
4.2.4.1.2 Europe Interventional Oncology Devices Market (by Embolization Devices)
4.2.5 Europe Interventional Oncology Devices Market (by Country)
4.2.5.1 Germany
4.2.5.1.1 Market
4.2.5.1.1.1 Business Restraints
4.2.5.1.1.2 Business Drivers
4.2.5.1.1.3 Sizing and Forecast Analysis
4.2.5.1.2 Application
4.2.5.1.2.1 Germany Interventional Oncology Devices Market (by Cancer Type)
4.2.5.1.2.2 Germany Interventional Oncology Devices Market (by End User)
4.2.5.1.3 Product
4.2.5.1.3.1 Germany Interventional Oncology Devices Market (by Product Type)
4.2.5.1.3.1.1 Germany Interventional Oncology Devices Market (by Ablation Devices)
4.2.5.1.3.1.2 Germany Interventional Oncology Devices Market (by Embolization Devices)
4.2.5.2 France
4.2.5.2.1 Market
4.2.5.2.1.1 Business Restraints
4.2.5.2.1.2 Business Drivers
4.2.5.2.1.3 Sizing and Forecast Analysis
4.2.5.2.2 Application
4.2.5.2.2.1 France Interventional Oncology Devices Market (by Cancer Type)
4.2.5.2.2.2 France Interventional Oncology Devices Market (by End User)
4.2.5.2.3 Product
4.2.5.2.3.1 France Interventional Oncology Devices Market (by Product Type)
4.2.5.2.3.1.1 France Interventional Oncology Devices Market (by Ablation Devices)
4.2.5.2.3.1.2 France Interventional Oncology Devices Market (by Embolization Devices)
4.2.5.3 U.K.
4.2.5.3.1 Market
4.2.5.3.1.1 Business Restraints
4.2.5.3.1.2 Business Drivers
4.2.5.3.1.3 Sizing and Forecast Analysis
4.2.5.3.2 Application
4.2.5.3.2.1 U.K. Interventional Oncology Devices Market (by Cancer Type)
4.2.5.3.2.2 U.K. Interventional Oncology Devices Market (by End User)
4.2.5.3.3 Product
4.2.5.3.3.1 U.K. Interventional Oncology Devices Market (by Product Type)
4.2.5.3.3.1.1 U.K. Interventional Oncology Devices Market (by Ablation Devices)
4.2.5.3.3.1.2 U.K. Interventional Oncology Devices Market (by Embolization Devices)
4.2.5.4 Italy
4.2.5.4.1 Market
4.2.5.4.1.1 Business Restraints
4.2.5.4.1.2 Business Drivers
4.2.5.4.1.3 Sizing and Forecast Analysis
4.2.5.4.2 Application
4.2.5.4.2.1 Italy Interventional Oncology Devices Market (by Cancer Type)
4.2.5.4.2.2 Italy Interventional Oncology Devices Market (by End User)
4.2.5.4.3 Product
4.2.5.4.3.1 Italy Interventional Oncology Devices Market (by Product Type)
4.2.5.4.3.1.1 Italy Interventional Oncology Devices Market (by Ablation Devices)
4.2.5.4.3.1.2 Italy Interventional Oncology Devices Market (by Embolization Devices)
4.2.5.5 Rest-of-Europe
4.2.5.5.1 Market
4.2.5.5.1.1 Business Restraints
4.2.5.5.1.2 Business Drivers
4.2.5.5.1.3 Sizing and Forecast Analysis
4.2.5.5.2 Application
4.2.5.5.2.1 Rest-of-Europe Interventional Oncology Devices Market (by Cancer Type)
4.2.5.5.2.2 Rest-of-Europe Interventional Oncology Devices Market (by End User)
4.2.5.5.3 Product
4.2.5.5.3.1 Rest-of-Europe Interventional Oncology Devices Market (by Product Type)
4.3 Asia-Pacific Interventional Oncology Devices Market
4.3.1 Regulatory Framework
4.3.2 Market
4.3.2.1 Key Findings and Opportunity Assessment
4.3.2.2 Business Drivers
4.3.2.3 Business Restraints
4.3.2.4 Impact Analysis
4.3.2.5 Sizing and Forecast Analysis
4.3.3 Application
4.3.3.1 Asia-Pacific Interventional Oncology Devices Market (by Cancer Type)
4.3.3.2 Asia-Pacific Interventional Oncology Devices Market (by End User)
4.3.4 Product
4.3.4.1 Asia-Pacific Interventional Oncology Devices Market (by Product Type)
4.3.4.1.1 Asia-Pacific Interventional Oncology Devices Market (by Ablation Devices)
4.3.4.1.2 Asia-Pacific Interventional Oncology Devices Market (by Embolization Devices)
4.3.5 Asia-Pacific Interventional Oncology Devices Market (by Country)
4.3.5.1 China
4.3.5.1.1 Market
4.3.5.1.1.1 Business Restraints
4.3.5.1.1.2 Business Drivers
4.3.5.1.1.3 Sizing and Forecast Analysis
4.3.5.1.2 Application
4.3.5.1.2.1 China Interventional Oncology Devices Market (by Cancer Type)
4.3.5.1.2.2 China Interventional Oncology Devices Market (by End User)
4.3.5.1.3 Product
4.3.5.1.3.1 China Interventional Oncology Devices Market (by Product Type)
4.3.5.1.3.1.1 China Interventional Oncology Devices Market (by Ablation Devices)
4.3.5.1.3.1.2 China Interventional Oncology Devices Market (by Embolization Devices)
4.3.5.2 Japan
4.3.5.2.1 Market
4.3.5.2.1.1 Business Restraints
4.3.5.2.1.2 Business Drivers
4.3.5.2.1.3 Sizing and Forecast Analysis
4.3.5.2.2 Application
4.3.5.2.2.1 Japan Interventional Oncology Devices Market (by Cancer Type)
4.3.5.2.2.2 Japan Interventional Oncology Devices Market (by End User)
4.3.5.2.3 Product
4.3.5.2.3.1 Japan Interventional Oncology Devices Market (by Product Type)
4.3.5.2.3.1.1 Japan Interventional Oncology Devices Market (by Ablation Devices)
4.3.5.2.3.1.2 Japan Interventional Oncology Devices Market (by Embolization Devices)
4.3.5.3 India
4.3.5.3.1 Market
4.3.5.3.1.1 Business Restraints
4.3.5.3.1.2 Business Drivers
4.3.5.3.1.3 Sizing and Forecast Analysis
4.3.5.3.2 Application
4.3.5.3.2.1 India Interventional Oncology Devices Market (by Cancer Type)
4.3.5.3.2.2 India Interventional Oncology Devices Market (by End User)
4.3.5.3.3 Product
4.3.5.3.3.1 India Interventional Oncology Devices Market (by Product Type)
4.3.5.3.3.1.1 India Interventional Oncology Devices Market (by Ablation Devices)
4.3.5.3.3.1.2 India Interventional Oncology Devices Market (by Embolization Devices)
4.3.5.4 Australia
4.3.5.4.1 Market
4.3.5.4.1.1 Business Restraints
4.3.5.4.1.2 Business Drivers
4.3.5.4.1.3 Sizing and Forecast Analysis
4.3.5.4.2 Application
4.3.5.4.2.1 Australia Interventional Oncology Devices Market (by Cancer Type)
4.3.5.4.2.2 Australia Interventional Oncology Devices Market (by End User)
4.3.5.4.3 Product
4.3.5.4.3.1 Australia Interventional Oncology Devices Market (by Product Type)
4.3.5.4.3.1.1 Australia Interventional Oncology Devices Market (by Ablation Devices)
4.3.5.4.3.1.2 Australia Interventional Oncology Devices Market (by Embolization Devices)
4.3.5.5 Rest-of-Asia-Pacific
4.3.5.5.1 Market
4.3.5.5.1.1 Business Restraints
4.3.5.5.1.2 Business Drivers
4.3.5.5.1.3 Sizing and Forecast Analysis
4.3.5.5.2 Application
4.3.5.5.2.1 Rest-of-Asia-Pacific Interventional Oncology Devices Market (by Cancer Type)
4.3.5.5.2.2 Rest-of-Asia-Pacific Interventional Oncology Devices Market (by End User)
4.3.5.5.3 Product
4.3.5.5.3.1 Rest-of-Asia-Pacific Interventional Oncology Devices Market (by Product Type)
4.4 Rest-of-the-World Interventional Oncology Devices Market
4.4.1 Regulatory Framework
4.4.2 Market
4.4.2.1 Key Findings and Opportunity Assessment
4.4.2.2 Business Drivers
4.4.2.3 Business Restraints
4.4.2.4 Impact Analysis
4.4.2.5 Sizing and Forecast Analysis
4.4.3 Application
4.4.3.1 Rest-of-the-World Interventional Oncology Devices Market (by Cancer Type)
4.4.3.2 Rest-of-the-World Interventional Oncology Devices Market (by End User)
4.4.4 Product
4.4.4.1 Rest-of-the-World Interventional Oncology Devices Market (by Product Type)
4.4.4.1.1 Rest-of-the-World Interventional Oncology Devices Market (by Ablation Devices)
4.4.4.1.2 Rest-of-the-World Interventional Oncology Devices Market (by Embolization Devices)
4.4.5 Rest-of-the-World Interventional Oncology Devices Market (by Region)
4.4.5.1 Latin America
4.4.5.1.1 Market
4.4.5.1.1.1 Business Restraints
4.4.5.1.1.2 Business Drivers
4.4.5.1.1.3 Sizing and Forecast Analysis
4.4.5.1.2 Application
4.4.5.1.2.1 Latin America Interventional Oncology Devices Market (by Cancer Type)
4.4.5.1.2.2 Latin America Interventional Oncology Devices Market (by End User)
4.4.5.1.3 Product
4.4.5.1.3.1 Latin America Interventional Oncology Devices Market (by Product Type)
4.4.5.2 Middle East and Africa
4.4.5.2.1 Market
4.4.5.2.1.1 Business Restraints
4.4.5.2.1.2 Business Drivers
4.4.5.2.1.3 Sizing and Forecast Analysis
4.4.5.2.2 Application
4.4.5.2.2.1 Middle East and Africa Interventional Oncology Devices Market (by Cancer Type)
4.4.5.2.2.2 Middle East and Africa Oncology Devices Market (by End User)
4.4.5.2.3 Product
4.4.5.2.3.1 Middle East and Africa Interventional Oncology Devices Market (by Product Type)

5 Markets - Competitive Benchmarking & Company Profiles
5.1 Competitive Benchmarking and Company Profiles
5.1.1 Competitive Landscape
5.1.1.1 Key Strategies and Developments
5.1.1.1.1 Mergers and Acquisitions
5.1.1.1.2 Regulatory and Legal Activities
5.1.1.1.3 New Offerings
5.1.1.1.4 Partnerships, Alliances, and Business Expansion
5.1.1.1.5 Funding Activities
5.2 Market Share Analysis
5.3 Company Profiles
5.3.1 AngioDynamics, Inc.
5.3.1.1 Company Overview
5.3.1.2 Role of AngioDynamics, Inc. in the Global Interventional Oncology Devices Market
5.3.1.3 Financials
5.3.1.4 Recent Developments
5.3.1.5 SWOT Analysis
5.3.2 Becton, Dickinson and Company
5.3.2.1 Company Overview
5.3.2.2 Role of Becton, Dickinson, and Company in the Global Interventional Oncology Devices Market
5.3.2.3 Financials
5.3.2.4 Recent Developments
5.3.2.5 SWOT Analysis
5.3.3 Boston Scientific Corporation
5.3.3.1 Company Overview
5.3.3.2 Role of Boston Scientific Corporation in the Global Interventional Oncology Devices Market
5.3.3.3 Financials
5.3.3.4 Recent Developments
5.3.3.5 SWOT Analysis
5.3.4 Eckert & Ziegler BEBIG AG
5.3.4.1 Company Overview
5.3.4.2 Role of Eckert & Ziegler BEBIG AG in the Global Interventional Oncology Devices Market
5.3.4.3 Financials
5.3.4.4 Recent Developments
5.3.4.5 SWOT Analysis
5.3.5 HealthTronics, Inc.
5.3.5.1 Company Overview
5.3.5.2 Role of HealthTronics, Inc. in the Global Interventional Oncology Devices Market
5.3.5.3 SWOT Analysis
5.3.6 IceCure Medical Ltd
5.3.6.1 Company Overview
5.3.6.2 Role of IceCure Medical Ltd in the Global Interventional Oncology Devices Market
5.3.6.3 Recent Developments
5.3.6.4 SWOT Analysis
5.3.7 Johnson & Johnson
5.3.7.1 Company Overview
5.3.7.2 Role of Johnson & Johnson in the Global Interventional Oncology Devices Market
5.3.7.3 Financials
5.3.7.4 Recent Developments
5.3.7.5 SWOT Analysis
5.3.8 Medtronic plc
5.3.8.1 Company Overview
5.3.8.2 Role of Medtronic plc in the Global Interventional Oncology Devices Market
5.3.8.3 Financials
5.3.8.4 Recent Developments
5.3.8.5 SWOT Analysis
5.3.9 MedWaves, Inc.
5.3.9.1 Company Overview
5.3.9.2 Role of MedWaves, Inc. in the Global Interventional Oncology Devices Market
5.3.9.3 SWOT Analysis
5.3.10 Merit Medical Systems, Inc.
5.3.10.1 Company Overview
5.3.10.2 Role of Merit Medical Systems, Inc. in the Global Interventional Oncology Devices Market
5.3.10.3 Financials
5.3.10.4 Recent Developments
5.3.10.5 SWOT Analysis
5.3.11 Sanarus Technologies, Inc.
5.3.11.1 Company Overview
5.3.11.2 Role of Sanarus Technologies, Inc. in the Global Interventional Oncology Devices Market
5.3.11.3 SWOT Analysis
5.3.12 Sonablate Corp
5.3.12.1 Company Overview
5.3.12.2 Role of Sonablate Corp in the Global Interventional Oncology Devices Market
5.3.12.3 Recent Developments
5.3.12.4 SWOT Analysis
5.3.13 Terumo Corporation
5.3.13.1 Company Overview
5.3.13.2 Role of Terumo Corporation in the Global Interventional Oncology Devices Market
5.3.13.3 Financials
5.3.13.4 Recent Developments
5.3.13.5 SWOT Analysis
5.3.14 Trod Medical
5.3.14.1 Company Overview
5.3.14.2 Role of Trod Medical in the Global Interventional Oncology Devices Market
5.3.14.3 Recent Developments
5.3.14.4 SWOT Analysis
5.3.15 Varian Medical Systems, Inc.
5.3.15.1 Company Overview
5.3.15.2 Role of Varian Medical Systems, Inc. in the Global Interventional Oncology Devices Market
5.3.15.3 Financials
5.3.15.4 Recent Developments
5.3.15.5 SWOT Analysis

6 Research Methodology
6.1 Data Collection and Analysis
6.2 Data Sources
6.2.1 Primary Sources
6.2.2 Secondary Sources
6.3 Data Triangulation
6.4 Market Estimation
6.5 Assumptions and Limitation

List of Figures
Figure 1: Number of People with Cancer (by Age) in Global Population, 1975-2020
Figure 2: Global Interventional Oncology Devices Market, $Million, 2020-2030
Figure 3: Global Interventional Oncology Devices Market, Impact Analysis
Figure 4: Global Interventional Oncology Devices Market, Industry Analysis
Figure 5: Global Interventional Oncology Devices Market, Competitive Benchmarking
Figure 6: Global Interventional Oncology Devices Market (by Product Type), 2020 Vs. 2030
Figure 7: Global Interventional Oncology Devices Market (by Cancer Type), 2020 Vs. 2030
Figure 8: Global Interventional Oncology Devices Market (by Region), 2020 and 2030
Figure 9: Global Interventional Oncology Devices Market Segmentation
Figure 10: Global Interventional Oncology Devices Market, Realistic Growth Scenario, $Million, 2020-2030
Figure 11: Global Interventional Oncology Devices Market, Optimistic Growth Scenario, $Million, 2020-2030
Figure 12: Global Interventional Oncology Devices Market, Pessimistic Growth Scenario, $Million, 2020-2030
Figure 13: Global Interventional Oncology Devices Market, Short-Term Potential, $Million, 2020-2025
Figure 14: Global Interventional Oncology Devices Market, Long-Term Growth, $Million, 2025-2030
Figure 15: Global Interventional Oncology Devices Market, Patent Publication Growth Trend, January 2015-September 2021
Figure 16: Global Interventional Oncology Devices Market, Patent Filing Trend (by Country/Cluster)
Figure 17: Global Interventional Oncology Devices Market, Impact Analysis
Figure 18: Global Interventional Oncology Devices Market (by Cancer Type)
Figure 19: Global Interventional Oncology Devices Market Incremental Opportunity (by Cancer Type), $Million, 2020-2030
Figure 20: Global Interventional Oncology Devices Market, Growth Share Matrix (by Cancer Type),2020-2030
Figure 21: Global Interventional Oncology Devices Market (by Liver Cancer), $Million, 2020-2030
Figure 22: Global Interventional Oncology Devices Market (by Lung Cancer), $Million, 2020-2030
Figure 23: Global Interventional Oncology Devices Market (by Kidney Cancer), $Million, 2020-2030
Figure 24: Global Interventional Oncology Devices Market (by Prostate Cancer), $Million, 2020-2030
Figure 25: Global Interventional Oncology Devices Market (by Other Cancers), $Million, 2020-2030
Figure 26: Global Interventional Oncology Devices Market (by End User)
Figure 27: Global Interventional Oncology Devices Market Incremental Opportunity (by End User), $Million, 2020-2030
Figure 28: Global Interventional Oncology Devices Market, Growth Share Matrix (by End User), 2020-2030
Figure 29: Global Interventional Oncology Devices Market (by Hospitals), $Million, 2020-2030
Figure 30: Global Interventional Oncology Devices Market (by Ambulatory Surgical Centers), $Million, 2020-2030
Figure 31: Global Interventional Oncology Devices Market (by Others), $Million, 2020-2030
Figure 32: Global Interventional Oncology Devices Market (by Product Type)
Figure 33: Global Interventional Oncology Devices Market Incremental Opportunity (by Product Type), $Million, 2020-2030
Figure 34: Global Interventional Oncology Devices Market, Growth Share Matrix (by Product Type), 2020-2030
Figure 35: Global Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 36: Global Ablation Devices Market (by Radiofrequency Ablation), $Million, 2020-2030
Figure 37: Global Ablation Devices Market (by Microwave Ablation), $Million, 2020-2030
Figure 38: Global Ablation Devices Market (by Cryoablation), $Million, 2020-2030
Figure 39: Global Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 40: Global Embolization Devices Market (by Transcatheter Arterial Chemoembolization), $Million, 2020-2030
Figure 41: Global Embolization Devices Market (by Transcatheter Arterial Radioembolization), $Million, 2020-2030
Figure 42: Global Embolization Devices Market (by Transcatheter Arterial Embolization), $Million, 2020-2030
Figure 43: Global Interventional Oncology Devices Market (by Supporting Devices), $Million, 2020-2030
Figure 44: Global Supporting Devices Market (by Catheters), $Million, 2020-2030
Figure 45: Global Supporting Devices Market (by Guidewires), $Million, 2020-2030
Figure 46: Global Interventional Oncology Devices Market (by Next-Generation Devices), $Million, 2020-2030
Figure 47: Global Next-Generation Devices Market (by Laser Ablation), $Million, 2020-2030
Figure 48: Global Next-Generation Devices Market (by High Intensity Focused Ultrasound), $Million, 2020-2030
Figure 49: Global Next-Generation Devices Market (by Irreversible Electroporation Ablation), $Million, 2020-2030
Figure 50: Global Next-Generation Devices Market (by Photothermal Ablation), $Million, 2020-2030
Figure 51: Global Next-Generation Devices Market (by Percutaneous Ethanol Ablation), $Million, 2020-2030
Figure 52: Global Next-Generation Devices Market (by Theranostics), $Million, 2020-2030
Figure 53: Global Interventional Oncology Devices Market (by Region), 2020 and 2030
Figure 54: North America Interventional Oncology Devices Market Incremental Growth Opportunity (by Country), $Million, 2020-2030
Figure 55: North America Interventional Oncology Devices Market, $Million, 2020-2030
Figure 56: North America Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 57: North America Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 58: North America Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 59: North America Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 60: North America Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 61: U.S. Interventional Oncology Devices Market, $Million, 2020-2030
Figure 62: U.S. Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 63: U.S. Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 64: U.S. Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 65: U.S. Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 66: U.S. Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 67: Canada Interventional Oncology Devices Market, $Million, 2020-2030
Figure 68: Canada Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 69: Canada Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 70: Canada Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 71: Canada Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 72: Canada Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 73: Europe Interventional Oncology Devices Market Incremental Growth Opportunity, $Million, 2020-2030
Figure 74: Europe Interventional Oncology Devices Market, $Millon, 2020-2030
Figure 75: Europe Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 76: Europe Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 77: Europe Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 78: Europe Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 79: Europe Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 80: Germany Interventional Oncology Devices Market, $Million, 2020-2030
Figure 81: Germany Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 82: Germany Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 83: Germany Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 84: Germany Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 85: Germany Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 86: France Interventional Oncology Devices Market, $Million, 2020-2030
Figure 87: France Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 88: France Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 89: France Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 90: France Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 91: France Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 92: U.K. Interventional Oncology Devices Market, $Million, 2020-2030
Figure 93: U.K. Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 94: U.K. Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 95: U.K. Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 96: U.K. Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 97: U.K. Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 98: Italy Interventional Oncology Devices Market, $Million, 2020-2030
Figure 99: Italy Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 100: Italy Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 101: Italy Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 102: Italy Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 103: Italy Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 104: Rest-of-Europe Interventional Oncology Devices Market, $Million, 2020-2030
Figure 105: Rest-of-Europe Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 106: Rest-of-Europe Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 107: Rest-of-Europe Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 108: Asia-Pacific Interventional Oncology Devices Market Incremental Growth Opportunity, $Million, 2020-2030
Figure 109: Asia-Pacific Interventional Oncology Devices Market, $Million, 2020-2030
Figure 110: Asia-Pacific Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 111: Asia-Pacific Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 112: Asia-Pacific Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 113: Asia-Pacific Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 114: Asia-Pacific Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 115: China Interventional Oncology Devices Market, $Million, 2020-2030
Figure 116: China Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 117: China Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 118: China Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 119: China Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 120: China Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 121: Japan Interventional Oncology Devices Market, $Million, 2020-2030
Figure 122: Japan Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 123: Japan Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 124: Japan Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 125: Japan Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 126: Japan Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 127: India Interventional Oncology Devices Market, $Million, 2020-2030
Figure 128: India Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 129: India Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 130: India Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 131: India Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 132: India Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 133: Australia Interventional Oncology Devices Market, $Million, 2020-2030
Figure 134: Australia Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 135: Australia Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 136: Australia Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 137: Australia Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 138: Australia Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 139: Rest-of-Asia-Pacific Interventional Oncology Devices Market, $Million, 2020-2030
Figure 140: Rest-of-Asia-Pacific Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 141: Rest-of-Asia-Pacific Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 142: Rest-of-Asia-Pacific Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 143: Rest-of-the-World Interventional Oncology Devices Market Incremental Growth Opportunity, $Million, 2020 -2030
Figure 144: Rest-of-the-World Interventional Oncology Devices Market, $Million, 2020-2030
Figure 145: Rest-of-The-World Interventional Oncology Devices Market (by Cancer Type),$Million, 2020-2030
Figure 146: Rest-of-the-World Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 147: Rest-of-the-World Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 148: Rest-of-the-World Interventional Oncology Devices Market (by Ablation Devices), $Million, 2020-2030
Figure 149: Rest-of-the-World Interventional Oncology Devices Market (by Embolization Devices), $Million, 2020-2030
Figure 150: Latin America Interventional Oncology Devices Market, $Million, 2020-2030
Figure 151: Latin America Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 152: Latin America Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 153: Latin America Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 154: Middle East and Africa Interventional Oncology Devices Market, $Million, 2020-2030
Figure 155: Middle East and Africa Interventional Oncology Devices Market (by Cancer Type), $Million, 2020-2030
Figure 156: Middle East and Africa Interventional Oncology Devices Market (by End User), $Million, 2020-2030
Figure 157: Middle East and Africa Interventional Oncology Devices Market (by Product Type), $Million, 2020-2030
Figure 158: Share of Key Developments and Strategies, January 2015-September 2021
Figure 159: Mergers and Acquisitions Share (by Company), January 2015-September 2021
Figure 160: Regulatory and Legal Activities Share (by Company), January 2015-September 2021
Figure 161: New Offerings Share (by Company), January 2015-September 2021
Figure 162: Partnerships, Alliances, and Business Expansion Share (by Company), January 2015-September 2021
Figure 163: Funding Activities Share (by Company), January 2015-September 2021
Figure 164: Market Share Analysis (by Company) for the Global Interventional Oncology Devices Market, 2020
Figure 165: AngioDynamics, Inc.: Overall Product Portfolio
Figure 166: AngioDynamics, Inc.: Overall Financials, $Million, 2018-2020
Figure 167: AngioDynamics,Inc.: Revenue (by Product Segment), $Million, 2018-2020
Figure 168: AngioDynamics, Inc.: Revenue (by Region), $Million,2018-2020
Figure 169: AngioDynamics, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 170: Becton, Dickinson and Company: Overall Product Portfolio
Figure 171: Becton, Dickinson and Company: Overall Financials, $Million, 2018-2020
Figure 172: Becton, Dickinson and Company: Revenue (by Product Segment), $Million, 2018-2020
Figure 173: Becton, Dickinson and Company: Revenue (by Region), $Million, 2018-2020
Figure 174: Becton, Dickinson, and Company: R&D Expenditure, $Million, 2018-2020
Figure 175: Boston Scientific Corporation: Overall Product Portfolio
Figure 176: Boston Scientific Corporation: Overall Financials, $Million, 2018-2020
Figure 177: Boston Scientific Corporation: Revenue (by Business Segment), $Million, 2018-2020
Figure 178: Boston Scientific Corporation: Revenue (by Region),$Million, 2018-2020
Figure 179: Boston Scientific Corporation: R&D Expenditure, $Million, 2018-2020
Figure 180: Eckert & Ziegler BEBIG AG: Overall Product Portfolio
Figure 181: Eckert & Ziegler BEBIG AG: Overall Financials, $Million, 2018-2020
Figure 182: Eckert & Ziegler BEBIG AG: Revenue (by Product Segment),$Million, 2018
Figure 183: Eckert & Ziegler BEBIG AG: Revenue (by Product Segment),$Million, 2019-2020
Figure 184: Eckert & Ziegler BEBIG AG: Revenue (by Region),$Million, 2018-2020
Figure 185: Eckert & Ziegler BEBIG AG: R&D Expenditure, $Million, 2018-2020
Figure 186: HealthTronics, Inc.: Overall Product Portfolio
Figure 187: IceCure Medical Ltd.: Overall Product Portfolio
Figure 188: Johnson & Johnson: Overall Product Portfolio
Figure 189: Johnson & Johnson: Overall Financials, $Million, 2018-2020
Figure 190: Johnson & Johnson: Revenue (by Product Segment), $Million, 2018-2020
Figure 191: Johnson & Johnson: Revenue (by Region), $Million, 2018-2020
Figure 192: Johnson & Johnson: R&D Expenditure, $Million, 2018-2020
Figure 193: Medtronic plc: Overall Product Portfolio
Figure 194: Medtronic plc: Overall Financials, $Million, 2018-2020
Figure 195: Medtronic plc: Revenue (by Segment), $Million, 2018-2020
Figure 196: Medtronic plc: Revenue (by Region), $Million,2018-2020
Figure 197: Medtronic plc: R&D Expenditure, $Million, 2018-2020
Figure 198: MedWaves, Inc.: Overall Product Portfolio
Figure 199: Merit Medical Systems, Inc.: Overall Product Portfolio
Figure 200: Merit Medical Systems, Inc.: Overall Financials, $Million,2018-2020
Figure 201: Merit Medical Systems, Inc.: Revenue (by Product Segment), $Million, 2018-2020
Figure 202: Merit Medical Systems, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 203: Merit Medical Systems, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 204: Sanarus Technologies, Inc.: Overall Product Portfolio
Figure 205: Sonablate Corp: Overall Product Portfolio
Figure 206: Terumo Corporation: Overall Product Portfolio
Figure 207: Terumo Corporation: Overall Financials, $Million, 2018-2020
Figure 208: Terumo Corporation: Revenue (by Segment),$Million, 2018-2020
Figure 209: Terumo Corporation: Revenue (by Region), $Million, 2018-2020
Figure 210: Terumo Corporation: R&D Expenditure, $Million, 2018-2020
Figure 211: Trod Medical: Overall Product Portfolio
Figure 212: Varian Medical Systems, Inc.: Overall Product Portfolio
Figure 213: Varian Medical Systems, Inc.: Overall Financials, $Million, 2017-2019
Figure 214: Varian Medical Systems, Inc.: Revenue (by Business Segment), $Million, 2017-2019
Figure 215: Varian Medical Systems, Inc.: Revenue (by Region), $Million,2017-2019
Figure 216: Varian Medical Systems, Inc.: R&D Expenditure, $Million, 2017-2019
Figure 217: Interventional Oncology Devices Market Research Methodology
Figure 218: Primary Research
Figure 219: Secondary Research
Figure 220: Data Triangulation
Figure 221: Bottom-Up Approach
Figure 222: Assumptions and Limitations

List of Tables
Table 1: Global Interventional Oncology Devices Market, Key Trends
Table 2: Global Interventional Oncology Devices Market, Awaited Technology Developments
Table 3: Global Interventional Oncology Devices Market, Product Benchmarking
Table 4: Global Interventional Oncology Devices Market, Ongoing Clinical Trial Studies
Table 5: Global Age Standardized Cancer Rates (Per 100,000 People) (by Country), 2018
Table 6: Reimbursement Scenario for Hepatic Embolization in the U.S., 2018
Table 7: Reimbursement Scenario for Renal Embolization in the U.S., 2018
Table 8: North America Interventional Oncology Devices Market Regulatory Framework
Table 9: North America Interventional Oncology Devices Market Dynamics Impact Analysis
Table 10: Canadian Cancer Statistics Snapshot of Incidence, Mortality and Survival Estimates (by Cancer Type), 2019
Table 11: Challenges in MDR Implementation
Table 12: Europe Interventional Oncology Devices Market Dynamics Impact Analysis
Table 13: Asia-Pacific Interventional Oncology Devices Market Regulatory Framework
Table 14: Asia-Pacific Interventional Oncology Devices Market Dynamics Impact Analysis
Table 15: Rest-of-the-World Interventional Oncology Devices Market Regulatory Framework
Table 16: Rest-of-the-World Interventional Oncology Devices Market Dynamics Impact Analysis

Companies Mentioned

• AngioDynamics, Inc.
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Eckert & Ziegler BEBIG AG
• HealthTronics, Inc.
• IceCure Medical Ltd
• Johnson & Johnson
• Medtronic plc
• MedWaves, Inc.
• Merit Medical Systems, Inc.
• Sanarus Technologies, Inc.
• Sonablate Corp
• Terumo Corporation
• Trod Medical
• Varian Medical Systems, Inc.